Therefore, further larger studies with better design characteristics are warranted to provide a clear picture of the effect of SGLT-2 inhibitors on the incidence of genital infections in patients with T2DM with concomitant CAD. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.